RxDoctor Payments Data

Joseph Brown, APRN

Family · Cabot, ARNPI 1245908292

Payments from drug & device makers

$3,523in general payments, 2019–2025

Across 207 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$839
  • AstraZeneca$515
  • Lilly USA, LLC$421
  • Novo Nordisk$374
  • Pfizer$212
  • GSK$152
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,523 in reported general payments places this provider in the 85th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$58,287
Medicare patients
262
Services billed
1,745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin59$47,879
MounjaroTirzepatide15$26,032
EliquisApixaban12$12,574
OzempicSemaglutide11$10,196
Breo ElliptaFluticasone/Vilanterol15$7,938
Combivent RespimatIpratropium/Albuterol Sulfate15$7,172
Venlafaxine Hcl ErVenlafaxine Hcl13$1,855
Duloxetine Hcl55$1,329
Gabapentin88$1,279
Pregabalin19$1,112
Albuterol Sulfate HfaAlbuterol Sulfate33$984
Atorvastatin Calcium100$811
Buspirone Hcl33$797
Levothyroxine Sodium110$779
Ventolin HfaAlbuterol Sulfate12$708

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat$100$55,05174 claims
Lilly USA, LLCMounjaro$421$26,03215 claims
PfizerEliquis$212$12,57412 claims
Novo NordiskOzempic$374$10,19611 claims
GSKBreo Ellipta$152$7,93815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,103 family providers in Arkansas.

Other family in Cabot

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →